Willingness to Pay for a COVID-19 Vaccine

datacite.creatorCerda, Arcadio A.
datacite.creatorGarcía Pérez, Leidy Yomary
datacite.date.issued2021
datacite.identifierDOI
datacite.identifier.doi10.1007/s40258-021-00644-6
datacite.identifier.issn1175-5652
datacite.identifier.orcid0000-0002-3791-854X
datacite.identifier.orcid0000-0002-7487-5999
datacite.identifier.wosidWOS:000620413600001
datacite.rightsAcceso Libre
datacite.titleWillingness to Pay for a COVID-19 Vaccine
dc.date.accessioned2024-11-08T12:34:35Z
dc.date.available2024-11-08T12:34:35Z
dc.description.abstractBackground The coronavirus disease (COVID-19) pandemic has considerably affected the lives of people worldwide, impacting their health and economic welfare, and changing the behavior of our society significantly. This situation may lead to a strong incentive for people to buy a vaccine. Therefore, a relevant study to assess individuals' choices and the value of change in welfare from a COVID-19 vaccine is essential. Objective This study aimed to estimate the willingness-to-pay (WTP) value for a vaccine for COVID-19. We also identify the variables that influence individual vaccination decisions, which could be used in the design of vaccination promotion strategies. Methods We use the contingent valuation method in its double-bounded dichotomous choice format. The estimation coefficients are calculated according to the maximum likelihood method under the assumption of a probit distribution. The sample consisted of 531 individuals, mainly from middle- and high-income socioeconomic groups from Chile between enrolled between 10 July and 10 August 2020. Results The results show a high WTP for the COVID-19 vaccine, with a value up to US$232. Income and education levels and having family members with COVID-19 increased the likelihood of persons paying for a vaccine. There is also a greater fear as the pandemic progresses that people will get sick from COVID-19. Conclusions The high WTP value creates an opportunity for formulating public health policy. The results of this study suggest that governments can provide the vaccine free to low-income groups and allow those with higher incomes to acquire the vaccine through the private sector by paying. This will be useful especially for countries with economic difficulties.
dc.description.pages9 p.
dc.identifier.urihttps://repositorio.utalca.cl/repositorio/handle/1950/14465
dc.languageInglés
dc.publisherSpringer
dc.relation.urihttps://link-springer-com.utalca.idm.oclc.org/article/10.1007/s40258-021-00644-6
dc.sourceAPPLIED HEALTH ECONOMICS AND HEALTH POLICY
oaire.citationTitleAPPLIED HEALTH ECONOMICS AND HEALTH POLICY
oaire.licenseConditionhttps://creativecommons.org/licenses/by-sa/4.0/deed.es
oaire.licenseCondition.urihttps://creativecommons.org/licenses/by-sa/4.0/deed.es
oaire.resourceTypeArtículo
oaire.versionVersión Publicada
utalca.catalogadorAGA
utalca.facultadUniversidad de Talca (Chile). Facultad de Economía y Negocios.
utalca.idcargaaga081124
utalca.indexArtículo indexado en Web of Science
utalca.indexArtículo indexado en Scopus
utalca.informaciondegeneroHombre y Mujer
utalca.odsSalud y bienestar
utalca.odsFin de la pobreza
utalca.odsReducción de las desigualdades
utalca.odsTrabajo decente y crecimiento económico
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
000620413600001.pdf
Size:
593.93 KB
Format:
Adobe Portable Document Format